Breaking News Instant updates and real-time market news.

CAT

Caterpillar

$112.89

0.6 (0.53%)

, TSLA

Tesla

$304.65

15.73 (5.44%)

10:37
10/25/18
10/25
10:37
10/25/18
10:37

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Caterpillar (CAT) upgraded to Hold from Sell at DZ Bank with analyst Robert Czerwensky upgrading the stock but lowering his price target to $119 from $127. 2. Tesla (TSLA) upgraded to Outperform from Peer Perform at Wolfe Research with analyst Dan Galves saying Q3 non-GAAP earnings of $2.90, versus consensus of 3c, and free cash flow of $881M is proof that Tesla's earnings power is likely to outperform traditional automakers. 3. Hilton (HLT) upgraded to Buy from Neutral at B. Riley FBR with analyst Jeffrey Donnelly saying the significant year-to-date underperformance of the shares, the majority of which took place in October, has created an attractive entry point. 4. Owens Corning (OC) upgraded to Overweight from Equal Weight at Barclays with analyst Matthew Bouley saying "Diminishing headwinds" in 2019 to support earnings growth off of a depressed base. 5. TripAdvisor (TRIP) upgraded to Neutral from Underperform at Credit Suisse with analyst Stephen Ju citing upcoming quarterly results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CAT

Caterpillar

$112.89

0.6 (0.53%)

TSLA

Tesla

$304.65

15.73 (5.44%)

HLT

Hilton

$67.18

3.39 (5.31%)

OC

Owens Corning

$45.08

2.015 (4.68%)

TRIP

TripAdvisor

$48.62

1.87 (4.00%)

  • 29

    Oct

  • 08

    Nov

  • 13

    Nov

  • 15

    Nov

  • 13

    Dec

CAT Caterpillar
$112.89

0.6 (0.53%)

10/24/18
MSCO
10/24/18
NO CHANGE
Target $169
MSCO
Overweight
Caterpillar steep discount not merited, says Morgan Stanley
Morgan Stanley analyst Courtney Yakavonis said Caterpillar was "punished" for its first in-line quarter and guidance reiteration since 2016, noting that investors have become "accustomed" to beat and raise reports from the heavy machinery maker. She believes the stock is priced as if EPS will decline in the next five months, but does not think such a steep discount is merited given that Resource Industries and Energy & Transportation are still below mid-cycle. Yakavonis keeps an Overweight rating as she continues to "like the risk reward here," but she lowered her price target on Caterpillar shares to $169 from $187.
10/24/18
RBCM
10/24/18
NO CHANGE
Target $142
RBCM
Sector Perform
Caterpillar price target lowered to $142 from $166 at RBC Capital
RBC Capital analyst Seth Weber lowered his price target on Caterpillar to $142 and kept his Sector Perform rating after its in-line Q3 results, saying the sell-off in the stock price "reflects angst over cycle duration". The analyst notes that the stock price is "relatively inexpensive" at 9.2-times forward earnings and the company has the "firepower to fund growth / return cash", but adds that he is also concerned with signs of a "potentially slowing demand", price/cost dynamics, and the global trade tensions that could limit the upside.
10/24/18
DZBN
10/24/18
UPGRADE
Target $119
DZBN
Hold
Caterpillar upgraded to Hold from Sell at DZ Bank
DZ Bank analyst Robert Czerwensky upgraded Caterpillar to Hold from Sell but lowered his price target to $119 from $127.
10/25/18
DZBN
10/25/18
UPGRADE
DZBN
Hold
Caterpillar upgraded to Hold from Sell at DZ Bank
TSLA Tesla
$304.65

15.73 (5.44%)

10/25/18
BARD
10/25/18
NO CHANGE
Target $411
BARD
Outperform
Tesla results changing company narrative, says Baird
Baird analyst Ben Kallo noted Tesla beat his and consensus estimates across the board, highlighted by strong free cash flow, which should help bolster the balance sheet and mitigate concerns over cash burn. The analyst feels the quarter should change the narrative on the company as it transitions to becoming sustainably profitable. Kallo reiterated his Buy rating and $411 price target on Tesla shares.
10/25/18
JMPS
10/25/18
NO CHANGE
Target $412
JMPS
Outperform
Tesla price target raised to $412 from $350 at JMP Securities
JMP Securities analyst Joseph Osha noted Tesla's Q3 results beat his estimates by "a decent margin" on the top line and "a dramatic margin" in terms of earnings, which demonstrates it is capable of generating positive earnings and cash flow as it shifts to a high-volume business model. Based on a moderately higher gross margin outlook for 2019 and 2020, and lower estimates for operating costs, he raised his price target on Tesla shares to $412 and keeps an Outperform rating on the stock.
10/25/18
OPCO
10/25/18
NO CHANGE
Target $418
OPCO
Outperform
Tesla price target raised to $418 from $385 at Oppenheimer
Oppenheimer analyst Colin Rusch raised his price target for Tesla to $418 from $385 after the company delivered positive cash flow in Q3 well ahead of expectations at $740M in free cash flow. All eyes now turn to the 2019 debt maturities, capital needs for its China capacity expansion, and depth of demand for Model 3, he contends. With about $890M in convertible notes due March 2019 with a strike price of $359.87 and about $525M due November 2019 at $759.36, the analyst expects Tesla to hope shares trade above the March 2019 conversion price and pursue a new fixed income instrument to address capex and the November 2019 converts. Rusch reiterates an Outperform rating on the shares.
10/25/18
WOLF
10/25/18
UPGRADE
Target $410
WOLF
Outperform
Tesla upgraded to Outperform from Peer Perform at Wolfe Research
Wolfe Research analyst Dan Galves upgraded Tesla to Outperform from Peer Perform with a $410 price target. Galves said Q3 non-GAAP earnings of $2.90, versus consensus of 3c, and free cash flow of $881M is proof that Tesla's earnings power is likely to outperform traditional automakers. Management's focus on cost and capital efficiency boosted Galves' confidence that priorities have changed from unit growth at all cost to profitable growth and self-funding. Galves said demand and the margin outlook appears "very positive" and the fact that 50% of trade-ins on the Model 3 are non-luxury vehicles indicates the buyer base is likely bigger than expected.
HLT Hilton
$67.18

3.39 (5.31%)

10/22/18
COWN
10/22/18
INITIATION
COWN
Outperform
Hilton initiated with an Outperform at Cowen
Cowen analyst Kevin Kopelman initiated Hilton with an Outperform rating and $81 price target, calling the company "well-positioned" due to its industry leading revenue premium at Hilton hotels, strong pipeline trend, and growing Hilton Honors program.
10/25/18
RILY
10/25/18
UPGRADE
Target $85
RILY
Buy
Hilton upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Bryan Maher upgraded Hilton Worldwide to Buy while lowering his price target for the shares to $85 from $91. The analyst cites valuation for the upgrade following the post-earnings selloff.
10/25/18
WELS
10/25/18
UPGRADE
Target $74
WELS
Outperform
Hilton upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly upgraded Hilton Worldwide to Outperform while lowering his price target for the shares to $74 from $87. The significant year-to-date underperformance of the shares, the majority of which took place in October, has created an attractive entry point, Donnelly tells investors in a research note. B. Riley FBR also upgraded Hilton this morning. Donnelly estimates that top 25 U.S. market RevPAR will be steady at 3%, the midpoint of Hilton's 2019 guidance. Further, he views the company's earnings model as "resilient" and feels its buyback program could support the stock.
10/25/18
BARD
10/25/18
NO CHANGE
Target $84
BARD
Outperform
Hilton weakness a buying opportunity, says Baird
Baird analyst Michael Bellisario said the weakness in Hilton has created an attractive buying opportunity. He noted sentiment has turned negative on broader cyclical growth concerns despite underlying supply and demand fundamentals that remain quite stable. Bellisario reiterated his Outperform rating, though he lowered his price target to $84 from $88 on Hilton shares.
OC Owens Corning
$45.08

2.015 (4.68%)

10/25/18
LEHM
10/25/18
UPGRADE
Target $58
LEHM
Overweight
Barclays upgrades Owens Corning to Overweight on 'diminishing headwinds'
Barclays analyst Matthew Bouley upgraded Owens Corning to Overweight from Equal Weight while lowering his price target for the shares to $58 from $62. "Diminishing headwinds" in 2019 to support earnings growth off of a depressed base, Bouley tells investors in a research note partially titled "Raise the Roof." With near-term expectations now reset, the valuation gives too little credit to the likelihood of recovery across the company's three segments next year, the analyst contends. He believes 18% fiscal 2019 earnings growth is achievable with visibility to a recovery in Roofing and Composites, and sustained price improvement in Insulation.
10/25/18
JEFF
10/25/18
NO CHANGE
Target $73
JEFF
Buy
Jefferies drops Owens Corning target, removes from Franchise Pick List
Jefferies analyst Philip Ng removed Owens Corning from his firm's Franchise Pick List and lowered his price target for the shares to $73 from $88 following the company's Q3 results. The analyst cites the "uneven results and low visibility in roofing" for the changes, but keeps a Buy rating on the shares. The analyst is "encouraged" by the pricing momentum in insulation and roofing and believes expectations are now reset to "very beatable levels."
10/25/18
RHCO
10/25/18
NO CHANGE
Target $45
RHCO
Hold
Owens Corning price target lowered to $45 from $70 at SunTrust
SunTrust analyst Keith Hughes lowered his price target on Owens Corning to $45 and kept his Hold rating after weaker than expected Q3 results and soft guidance. The analyst expects the soft roofing conditions to persist into the next quarter but also notes that the price-cost dynamic turned positive, which he sees as an "important development". Hughes adds that the weak insulation and composite segments were a surprise, but sees a lot of "bad" priced in to the stock at 5.9-times multiple for enterprise value to his expected FY19 EBITDA.
10/25/18
FBCO
10/25/18
NO CHANGE
Target $47
FBCO
Neutral
Owens Corning price target lowered to $47 from $57 at Credit Suisse
Credit Suisse analyst Susan Maklari lowered her price target for Owens Corning to $47 from $57 saying that the company's Q3 results further her Neutral rating stance. Although pricing over the last several quarters-especially in roofing and insulation-allowed it to catch up with inflation, volumes across geographies were below expectations, she contends. Maklari also notes that the outlook for more subdued activity through the end of 2018 is also limiting upside to results.
TRIP TripAdvisor
$48.62

1.87 (4.00%)

10/15/18
EVER
10/15/18
INITIATION
EVER
In Line
TripAdvisor initiated with an In Line at Evercore ISI
Evercore ISI analyst Anthony DiClemente initiated coverage of the online travel sector with a mixed outlook, starting TripAdvisor (TRIP) with an In Line rating. While the offline to online shift may have slowed, the travel market itself remains fragmented, leaving open the opportunity for share gains, said DiClemente, who calls Expedia (EXPE) his top pick in the space.
10/25/18
10/25/18
UPGRADE
Target $51

Neutral
TripAdvisor upgraded to Neutral ahead of Q3 results at Credit Suisse
As previously reported, Credit Suisse analyst Stephen Ju upgraded TripAdvisor to Neutral from Underperform ahead of quarterly results. The analyst also raised his price target on the shares to $51 from $44.
10/25/18
FBCO
10/25/18
UPGRADE
FBCO
Neutral
TripAdvisor upgraded to Neutral from Underperform at Credit Suisse
10/16/18
10/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abbott (ABT), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT) were initiated with an Overweight at Barclays, while Baxter (BAX), Edwards Lifesciences (EW), and Zimmer Biomet (ZBH) were initiated with an Underweight. 2. Expedia (EXPE) was initiated with an Outperform at Evercore ISI, while TripAdvisor (TRIP) was initiated with an In Line, and Booking Holdings (BKNG) was initiated with an In Line. 3. Facebook (FB) was initiated with a Buy at Loop Capital and Rosenblatt. 4. Snap (SNAP) initiated with a Hold at Loop Capital. 5. VF Corp. (VFC) initiated with a Neutral at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CTTAY

Continental AG

$0.00

(0.00%)

21:26
06/16/19
06/16
21:26
06/16/19
21:26
Downgrade
Continental AG rating change  »

Continental AG downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YARIY

Yara

$0.00

(0.00%)

20:50
06/16/19
06/16
20:50
06/16/19
20:50
Downgrade
Yara rating change  »

Yara downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTVA

Corteva

$25.20

0.23 (0.92%)

20:49
06/16/19
06/16
20:49
06/16/19
20:49
Upgrade
Corteva rating change at Deutsche Bank »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$125.30

0.45 (0.36%)

, SNE

Sony

$51.42

1.735 (3.49%)

19:15
06/16/19
06/16
19:15
06/16/19
19:15
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

UTX

United Technologies

$125.30

0.45 (0.36%)

SNE

Sony

$51.42

1.735 (3.49%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GS

Goldman Sachs

$191.71

0.24 (0.13%)

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

BA

Boeing

$347.19

-1.54 (-0.44%)

RTN

Raytheon

$177.38

0.195 (0.11%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 23

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

GM

General Motors

$35.66

-0.36 (-1.00%)

18:49
06/16/19
06/16
18:49
06/16/19
18:49
Periodicals
GM won't deploy self-driving fleet until safer than human driver, Axios reports »

General Motors CEO Mary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 12

    Aug

T

AT&T

$32.36

0.06 (0.19%)

, CMCSA

Comcast

$42.31

0.62 (1.49%)

17:58
06/16/19
06/16
17:58
06/16/19
17:58
On The Fly
Box Office Battle: 'Men in Black: International' wins weekend with just $28.5M »

Sony’s (SNE) "Men in…

T

AT&T

$32.36

0.06 (0.19%)

CMCSA

Comcast

$42.31

0.62 (1.49%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.42

1.735 (3.49%)

LGF.A

Lionsgate

$12.22

-0.85 (-6.50%)

DIS

Disney

$141.64

-0.09 (-0.06%)

VIAB

Viacom

$29.38

-0.28 (-0.94%)

VIA

Viacom

$34.61

0.14 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

GS

Goldman Sachs

$191.71

0.24 (0.13%)

17:43
06/16/19
06/16
17:43
06/16/19
17:43
Periodicals
Goldman Sachs combining private-investing units, WSJ reports »

Goldman Sachs is pulling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

17:38
06/16/19
06/16
17:38
06/16/19
17:38
Periodicals
Deutsche Bank to set up EUR50B bad bank, Financial Times reports »

Deutsche Bank is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$87.10

(0.00%)

16:35
06/16/19
06/16
16:35
06/16/19
16:35
Periodicals
Tires blow on United jet during Newark airport landing, Reuters reports »

Tires on a United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$87.83

-0.48 (-0.54%)

16:33
06/16/19
06/16
16:33
06/16/19
16:33
Periodicals
Target registers back online after outage blamed on tech issue, Reuters says »

Target said its payment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.18

-0.54 (-1.16%)

16:30
06/16/19
06/16
16:30
06/16/19
16:30
Hot Stocks
Intel announces program for Israeli startups targeting tech inflections »

Intel announced a program…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:27
06/16/19
06/16
16:27
06/16/19
16:27
Periodicals
Boeing says will take time to rebuild customer confidence, Reuters reports »

The head of Boeing said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

GS

Goldman Sachs

$191.71

0.24 (0.13%)

16:19
06/16/19
06/16
16:19
06/16/19
16:19
Periodicals
Goldman Sachs skeptical of 'insurance' rate cuts from Fed, Reuters says »

Goldman Sachs economists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:16
06/16/19
06/16
16:16
06/16/19
16:16
Periodicals
Trials nearing for Boeing 737 Max fix, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

ESLT

Elbit Systems

$154.55

0.55 (0.36%)

13:41
06/16/19
06/16
13:41
06/16/19
13:41
Hot Stocks
Elbit Systems awarded $50M contract »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$176.09

-0.74 (-0.42%)

13:40
06/16/19
06/16
13:40
06/16/19
13:40
Hot Stocks
Amgen announces BLINCYTO five-year overall survival data »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

SILK

Silk Road Medical

$44.80

-0.95 (-2.08%)

13:35
06/16/19
06/16
13:35
06/16/19
13:35
Hot Stocks
Silk Road Medical announces final results for ROADSTER-2 study »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 26

    Aug

EDIT

Editas Medicine

$21.72

-0.78 (-3.47%)

13:30
06/16/19
06/16
13:30
06/16/19
13:30
Hot Stocks
Editas presents pre-clinical data in Sickle Cell Disease, Beta-Thalassemia »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.90

-0.055 (-5.79%)

13:28
06/16/19
06/16
13:28
06/16/19
13:28
Hot Stocks
Sunesis announces preliminary data from Phase 1b/2 trial of Vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

APLS

Apellis

$21.22

-0.14 (-0.66%)

13:23
06/16/19
06/16
13:23
06/16/19
13:23
Hot Stocks
Apellis presents data from ongoing Phase 2 PLAUDIT study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

FTSV

Forty Seven

$10.55

-0.02 (-0.19%)

13:16
06/16/19
06/16
13:16
06/16/19
13:16
Hot Stocks
Forty Seven announces data from Phase 1b/2 trial of 5F9 in combo with Rituximab »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

13:06
06/16/19
06/16
13:06
06/16/19
13:06
Hot Stocks
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

STRO

Sutro Biopharma

$11.17

-0.34 (-2.95%)

13:02
06/16/19
06/16
13:02
06/16/19
13:02
Hot Stocks
Sutro Biopharma announces interim Phase 1 safety data for STRO-001 »

Sutro Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$90.65

-0.35 (-0.38%)

12:59
06/16/19
06/16
12:59
06/16/19
12:59
Hot Stocks
Blueprint Medicines presents updated EXPLORER trial data for Avapritinib »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

INCY

Incyte

$77.76

1.385 (1.81%)

12:52
06/16/19
06/16
12:52
06/16/19
12:52
Hot Stocks
Incyte announced results from Phase 2 study of Ruxolitinib cream in vitiligo »

Incyte announces 24-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.